Cardinal Health Inc  

(Public, NYSE:CAH)   Watch this stock  
Find more results for CAH
+0.62 (0.86%)
Aug 21 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 72.44 - 73.45
52 week 49.65 - 74.40
Open 72.50
Vol / Avg. 1.62M/2.00M
Mkt cap 24.40B
P/E 21.70
Div/yield 0.34/1.87
EPS 3.37
Shares 336.65M
Beta 0.49
Inst. own 89%
Oct 29, 2014
Q1 2015 Cardinal Health Inc Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Sep 10, 2014
Cardinal Health Inc at Morgan Stanley Global Healthcare Unplugged Conference - 8:00AM EDT - Add to calendar
Aug 6, 2014
Cardinal Health Inc at Piper Jaffray Heartland Summit
Aug 4, 2014
Q4 2014 Cardinal Health, Inc. Earnings Release
Aug 4, 2014
Q4 2014 Cardinal Health Inc Earnings Call
Jun 11, 2014
Cardinal Health, Inc. at William Blair & Company LLC Growth Stock Conference (Breakout Session)
Jun 11, 2014
Cardinal Health, Inc. at William Blair & Company LLC Growth Stock Conference
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '14) 2014
Net profit margin 1.02% 1.28%
Operating margin 1.69% 2.07%
EBITD margin - 2.85%
Return on average assets 3.70% 4.49%
Return on average equity 14.51% 18.79%
Employees 33,600 -
CDP Score - 71 D


7000 Cardinal Place
DUBLIN, OH 43017
United States - Map
+1-614-7573033 (Phone)
+1-614-7576000 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia


Cardinal Health, Inc. is a healthcare services company providing pharmaceutical and medical products and services to pharmacies, hospitals, ambulatory surgery centers, clinical laboratories, physician offices and other healthcare providers. Its products and services include surgical clipper, topical skin adhesives, vitalsource and facial protection. The company is also a manufacturer of medical and surgical products, including gloves, surgical apparel and fluid management products. The Company operates in two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes and generic pharmaceutical, over-the-counter healthcare, and consumer products through its pharmaceutical distribution business to retailers. The Medical segment distributes a range of medical, surgical and laboratory products to hospitals, surgery centers, laboratories, physician offices and other healthcare providers. In May 2014, the Company acquired AccessClosure.

Officers and directors

George S. Barrett Chairman of the Board, Chief Executive Officer
Age: 58
Bio & Compensation  - Reuters
Jeffrey W. Henderson Chief Financial Officer
Age: 48
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Donald M. Casey Jr. Chief Executive Officer - Medical Segment
Age: 53
Bio & Compensation  - Reuters
Michael C. Kaufmann Chief Executive Officer - Pharmaceutical Segment
Age: 50
Bio & Compensation  - Reuters
Carole S. Watkins Chief Human Resource Officer
Age: 52
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Stephen T. Falk Executive Vice President, General Counsel, Corporate Secretary
Age: 48
Bio & Compensation  - Reuters
Mark R. Blake Executive Vice President - Strategy and Corporate Development
Age: 42
Bio & Compensation  - Reuters
Craig S. Morford Chief Legal and Compliance Officer
Age: 54
Bio & Compensation  - Reuters
Patricia A. Hemingway Hall Director
Age: 61
Bio & Compensation  - Reuters
David John Anderson Independent Director
Age: 64
Bio & Compensation  - Reuters